Close Menu

NEW YORK (GenomeWeb) – Maravai LifeSciences announced today that it has acquired Glen Research, a Virginia-based provider of DNA and RNA synthesis reagents.

Specific terms of the deal were not disclosed.

"The acquisition supports our commitment to the genomics market, which we first entered with the acquisition of TriLink BioTechnologies," Maravai President Eric Tardif said in a statement. Maravai acquired TriLink in 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.